Persistent docetaxel-induced supravenous erythematous eruption

Taxanes are drugs used to treat many types of cancer, including breast and lung cancer. The most common side effects of these drugs are neutropenia and mucositis. Signs of skin toxicity are observed in about 65% of cases and include alopecia, hypersensitivity reactions, persistent supravenous erythe...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Karina de Almeida Pinto, Felix, Paulo Antônio Oldani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631238/
https://www.ncbi.nlm.nih.gov/pubmed/26560218
http://dx.doi.org/10.1590/abd1806-4841.20153296
_version_ 1782398828262981632
author Fernandes, Karina de Almeida Pinto
Felix, Paulo Antônio Oldani
author_facet Fernandes, Karina de Almeida Pinto
Felix, Paulo Antônio Oldani
author_sort Fernandes, Karina de Almeida Pinto
collection PubMed
description Taxanes are drugs used to treat many types of cancer, including breast and lung cancer. The most common side effects of these drugs are neutropenia and mucositis. Signs of skin toxicity are observed in about 65% of cases and include alopecia, hypersensitivity reactions, persistent supravenous erythematous eruption, nail changes, scleroderma reactions and others. We report two cases of skin reaction to docetaxel and warn that it is not necessary to interrupt the treatment in these cases.
format Online
Article
Text
id pubmed-4631238
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-46312382015-11-04 Persistent docetaxel-induced supravenous erythematous eruption Fernandes, Karina de Almeida Pinto Felix, Paulo Antônio Oldani An Bras Dermatol Case Report Taxanes are drugs used to treat many types of cancer, including breast and lung cancer. The most common side effects of these drugs are neutropenia and mucositis. Signs of skin toxicity are observed in about 65% of cases and include alopecia, hypersensitivity reactions, persistent supravenous erythematous eruption, nail changes, scleroderma reactions and others. We report two cases of skin reaction to docetaxel and warn that it is not necessary to interrupt the treatment in these cases. Sociedade Brasileira de Dermatologia 2015 /pmc/articles/PMC4631238/ /pubmed/26560218 http://dx.doi.org/10.1590/abd1806-4841.20153296 Text en © 2015 by Anais Brasileiros de Dermatologia http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Fernandes, Karina de Almeida Pinto
Felix, Paulo Antônio Oldani
Persistent docetaxel-induced supravenous erythematous eruption
title Persistent docetaxel-induced supravenous erythematous eruption
title_full Persistent docetaxel-induced supravenous erythematous eruption
title_fullStr Persistent docetaxel-induced supravenous erythematous eruption
title_full_unstemmed Persistent docetaxel-induced supravenous erythematous eruption
title_short Persistent docetaxel-induced supravenous erythematous eruption
title_sort persistent docetaxel-induced supravenous erythematous eruption
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631238/
https://www.ncbi.nlm.nih.gov/pubmed/26560218
http://dx.doi.org/10.1590/abd1806-4841.20153296
work_keys_str_mv AT fernandeskarinadealmeidapinto persistentdocetaxelinducedsupravenouserythematouseruption
AT felixpauloantoniooldani persistentdocetaxelinducedsupravenouserythematouseruption

Ejemplares similares